
Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) has provided an update on the U.S. commercial launch for OLINVYK (oliceridine) injection and announced anticipated milestones for 2021.
Read More